Growth Metrics

Nu-Med Plus (NUMD) EBIAT (2012 - 2025)

Nu-Med Plus recorded quarterly EBIAT of -$12618.0 in Q4 2025, down 5.45% quarter-over-quarter from -$11966.0 in Q3 2025, and down 19.55% year-over-year from -$15683.3 in Q4 2024.

Nu-Med Plus' EBIAT history runs 14 years deep, the most recent figure standing at -$12618.0 for Q4 2025.

  • In Q4 2025, EBIAT fell 19.55% year-over-year to -$12618.0; the TTM figure through Dec 2025 stood at -$56182.0 (up 17.8% YoY), while the FY2025 annual figure was -$56182.0, up 17.8% from the prior year.
  • EBIAT came in at -$12618.0 for Q4 2025 at Nu-Med Plus, down from -$11966.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $42606.0 in Q4 2022 to a low of -$356748.0 in Q1 2021.
  • A 5-year average of -$60514.0 and a median of -$23073.0 in 2023 frame the typical range for EBIAT.
  • Across the five-year window, EBIAT soared 137.93% in 2022 and slumped 232.84% in 2023, its largest moves.
  • Nu-Med Plus' EBIAT stood at -$112341.0 in 2021, then jumped by 137.93% to $42606.0 in 2022, then plunged by 232.84% to -$56596.0 in 2023, then jumped by 81.35% to -$10555.0 in 2024, then retreated by 19.55% to -$12618.0 in 2025.
  • According to Business Quant data, EBIAT over the past three periods registered -$12618.0, -$11966.0, and -$11665.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIAT (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.14 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 170.93 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Nu-Med Plus - - - -12,618.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -12,618.00
Sep 30, 2025 -11,966.00
Jun 30, 2025 -11,665.00
Mar 31, 2025 -19,933.00
Dec 31, 2024 -10,555.00
Sep 30, 2024 -18,677.00
Jun 30, 2024 -17,287.00
Mar 31, 2024 -21,826.00
Dec 31, 2023 -56,596.00
Sep 30, 2023 -16,406.00
Jun 30, 2023 -24,320.00
Mar 31, 2023 -28,204.00
Dec 31, 2022 42,606.00
Sep 30, 2022 -58,050.00
Jun 30, 2022 -58,070.00
Mar 31, 2022 -56,653.00
Dec 31, 2021 -112,341.00
Sep 30, 2021 -118,366.00
Jun 30, 2021 -242,606.00
Mar 31, 2021 -356,748.00
Dec 31, 2020 -493,374.00
Sep 30, 2020 -453,824.00
Jun 30, 2020 -908,467.00
Mar 31, 2020 -153,334.00
Dec 31, 2019 -209,870.00
Sep 30, 2019 -150,576.00
Jun 30, 2019 -248,184.00
Mar 31, 2019 -428,195.00
Dec 31, 2018 -340,957.00
Sep 30, 2018 -526,848.00
Jun 30, 2018 -173,555.00
Mar 31, 2018 -147,486.00
Dec 31, 2017 -152,619.00
Sep 30, 2017 -142,977.00
Jun 30, 2017 -116,053.00
Mar 31, 2017 3.99 Mn
Dec 31, 2016 -319,515.00
Sep 30, 2016 -772,175.00
Jun 30, 2016 -228,029.00
Mar 31, 2016 10.97 Mn
Dec 31, 2015 -8.06 Mn
Sep 30, 2015 -307,378.00
Jun 30, 2015 -393,256.00
Mar 31, 2015 -122,593.00
Dec 31, 2014 -533,896.00
Sep 30, 2014 -242,944.00
Jun 30, 2014 -202,268.00
Mar 31, 2014 -213,625.00
Sep 30, 2013 -142,093.00
Jun 30, 2013 -36,675.00
Mar 31, 2013 -82,658.00
Dec 31, 2012 -266,385.00
Sep 30, 2012 -110,717.00
Jun 30, 2012 -46,241.00
Mar 31, 2012 -19,534.00